Covered recipient · General Payments record
ANNA JC TELEWICZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2023
$1,920.98
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $847.10 | 38 |
| Education | $21.00 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $79.48 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.52 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $44.92 | 3 |
| Astellas Pharma US Inc | $44.55 | 2 |
| Amgen Inc. | $43.74 | 2 |
| Celgene Corporation | $42.51 | 2 |
| PFIZER INC. | $41.33 | 2 |
| Janssen Biotech, Inc. | $40.89 | 2 |
| Mirati Therapeutics, Inc. | $40.05 | 2 |
| E.R. Squibb & Sons, L.L.C. | $39.83 | 2 |
| Merck Sharp & Dohme Corporation | $33.94 | 2 |
| BeiGene USA, Inc. | $33.70 | 1 |
| GlaxoSmithKline, LLC. | $29.17 | 1 |
| Pharmacyclics LLC, An AbbVie Company | $28.96 | 1 |
| PharmaEssentia USA Corporation | $25.89 | 1 |
| MorphoSys, US Inc. | $24.80 | 1 |
| Genentech USA, Inc. | $24.75 | 1 |
| Exelixis Inc. | $23.71 | 1 |
| Incyte Corporation | $23.32 | 1 |
| SEAGEN INC. | $22.72 | 1 |
| TAIHO ONCOLOGY, INC. | $22.62 | 1 |
| Lilly USA, LLC | $22.30 | 1 |
| Rigel Pharmaceuticals, Inc. | $21.15 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $20.36 | 1 |
| Alnylam Pharmaceuticals Inc. | $19.30 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $18.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (39)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.